î
îŒ
î
Collplant Biotechnologies Ltd
CLGNî¹
詳现ãã£ãŒãã衚瀺
2.515USD
-0.125-4.73%
çµå€Â 09/19, 16:00ïŒETïŒ15åé
ãã®æ ªäŸ¡
31.98Mæ䟡ç·é¡
æ倱é¡çŽè¿12ã¶æPER
î
Intraday
1m
30m
1h
D
W
M
D
æ¬æ¥
-4.73%
5æ¥é
-4.01%
1ã¶æ
+2.03%
6ã¶æ
-18.56%
幎åæ¥
-30.14%
1幎é
-46.72%
詳现ãã£ãŒãã衚瀺
TradingKey æ ªåŒã¹ã³ã¢î
é貚: USD æŽæ°æå»: 2025-09-19äž»èŠã€ã³ãµã€ã
å瀟ã®è²¡åç¶æ³ã¯æ¯èŒçéåžžã«å¥å šã§ããå瀟ã®æ ªäŸ¡ã¯å²å®ãšè©äŸ¡ãããŠããŸãããŸããæ©é¢æè³å®¶ã«ããèªç¥åºŠã¯éåžžã«é«ãã§ããéå»30æ¥éã§ãè€æ°ã®ã¢ããªã¹ããå瀟ãè²·ããšè©äŸ¡ããŸãããæ ªäŸ¡ã®ããã©ãŒãã³ã¹ã¯äœèª¿ã§ããããã¡ã³ãã¡ã³ã¿ã«ãºãšãã¯ãã«ã«ã¯å 調ã§ããæ ªäŸ¡ã¯æ¯æç·ãšæµæç·ã®éã§æšªã°ãæšç§»ããŠãããã¬ã³ãžçžå Žã§ã®ã¹ã€ã³ã°ãã¬ãŒãã«é©ããŠããŸãã
æ ªåŒã¹ã³ã¢î°î°
æ¯æç·ãšæµæç·
ããŒã¿ãªã
ã¬ãŒããŒãã£ãŒã
çŸåš
ååå€
ã¢ããªã¹ãç®æšæ ªäŸ¡
2
人ã®ã¢ããªã¹ãäºæ³ã«åºã¥ã
è²·ã
çŸåšã®è©äŸ¡
11.500
ç®æšæ ªäŸ¡
+335.61%
äžæäœå°
å
責äºé
ïŒã¢ããªã¹ãã®ã¬ãŒãã£ã³ã°ããã³ç®æšæ ªäŸ¡ã¯ãæ
å ±æäŸã®ã¿ãç®çãšããŠLSEG Data & AnalyticsãæäŸãããã®ã§ãããæè³å©èšãæ§æãããã®ã§ã¯ãããŸããã
äŒæ¥ãã€ã©ã€ã
匷ã¿ãªã¹ã¯
CollPlant Biotechnologies Ltd, formerly known as Collplant Holdings Ltd, is a company dealing in aesthetic medicine and regenerative medicine based in Israel. The company provides products and technologies for broadly understood regenerative medicine, including tissue regeneration and organ production. The technology is based on plants and is based on the production of collagen type I (rhCollagen).
é«æé·
å瀟ã®åçã¯éå»3幎éã«ãããçå®ã«å¢å ããŠããã幎平åã§72.24%ã®æé·çã瀺ããŠããŸãã
æé·äž
å瀟ã¯æé·ãã§ãŒãºã«ãããææ°ã®å¹Žéåçã¯USD 515.00Kã«éããŠããŸãã
é©æ£æ°Žæº
å瀟ã®ææ°ã®PEã¯-2.23ã§ãéå»3幎éã®æ°Žæºãšæ¯èŒããŠé©æ£åã«ãããŸãã
æ©é¢æè³å®¶ã®è²·ãå¢ã
ææ°ã®æ©é¢æè³å®¶ã®ä¿ææ ªæ°ã¯5.52Mæ ªã§ãåååææ¯ã§3.08%å¢å ããŠããŸãã
ãžã§ãŒã ãºã»ã·ã¢ã³ãºãä¿æ
ã¹ã¿ãŒæè³å®¶ãžã§ãŒã ãºã»ã·ã¢ã³ãºã¯æ¬éæã41.60Kæ ªä¿æããŠããŸãã
åžå ŽæŽ»åãäœèª¿
å瀟ãžã®æè³å®¶ã®é¢å¿ã¯äœäžããŠããã20æ¥éã®å£²è²·å転çã¯0.72ã§ãã
ãã¥ãŒã¹
ææ°æ
å ±ããåŸ
ã¡ãã ãã...
財åææšî
EPS
ããŒã¿ãªã
ç·å£²äžé«
ããŒã¿ãªã
äŒæ¥åî
CollPlant Biotechnologies Ltd, formerly known as Collplant Holdings Ltd, is a company dealing in aesthetic medicine and regenerative medicine based in Israel. The company provides products and technologies for broadly understood regenerative medicine, including tissue regeneration and organ production. The technology is based on plants and is based on the production of collagen type I (rhCollagen).
äŒæ¥ã³ãŒãCLGN
äŒæ¥åCollplant Biotechnologies Ltd
æé«çµå¶è²¬ä»»è
ãCEOãMr. Eran Rotem, CPA
ãŠã§ããµã€ãhttps://www.collplant.com
é¢é£éèåå
+0.68%
+1.38%
-2.48%
-1.57%
-0.75%
-0.09%
+1.34%
-1.77%
-0.67%
-3.03%
-0.85%
-0.87%
-0.50%
+0.44%
-0.19%
-1.18%
-2.84%
0.00%
+0.30%
-3.72%人æ°éæ
115887.80
+575.23Â (+0.50%)
4462.14
+5.52Â (+0.12%)
3685.06
+40.47Â (+1.11%)
62.207
-0.974Â (-1.54%)
1.17440
-0.00422Â (-0.36%)
147.896
-0.093Â (-0.06%)
43.050
+1.254Â (+3.00%)
0.65858
-0.00255Â (-0.39%)
1.34661
-0.00879Â (-0.65%)
596.90
-2.60Â (-0.43%)
